SOD1 oligomers in amyotrophic lateral sclerosis

被引:17
|
作者
Choi, Esther S. [1 ,2 ]
Dokholyan, Nikolay, V [1 ,3 ]
机构
[1] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA
[2] Penn State Coll Med, Med Scientist Training Program, Hershey, PA 17033 USA
[3] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA
基金
美国国家卫生研究院;
关键词
MOTOR-NEURONS; ALS; DISMUTASE; MODEL;
D O I
10.1016/j.sbi.2020.12.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Identifying nonnative, trimeric forms of SOD1 trimers as the toxic species, rather than large aggregates revolutionizes our understanding of ALS pathophysiology. Large protein aggregates, what was previously thought as the central cause of neurodegeneration, play protective role and are not responsible for neuronal death. SOD1 trimers are implicated at the molecular, cellular, and organismal level. Understanding the formation of the nonnative trimer and its role in the cell, leading to cell death, holds the key to developing a new standard of therapeutics for ALS and for other neurodegenerative diseases. This review highlights recent advances of knowledge for the role of SOD1 oligomers in ALS.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 50 条
  • [1] SOD1 mutations in amyotrophic lateral sclerosis
    Battistini, S
    Giannini, F
    Greco, G
    Bibbö, G
    Ferrera, L
    Marini, V
    Causarano, R
    Casula, M
    Lando, G
    Patrosso, M
    Caponnetto, C
    Origone, P
    Marocchi, A
    Del Corona, A
    Siciliano, G
    Carrera, P
    Mascia, V
    Giagheddu, M
    Carcassi, C
    Orrú, S
    Garrè, C
    Penco, S
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (07) : 782 - 788
  • [2] AMYOTROPHIC LATERAL SCLEROSIS AND SOD1 MUTATION
    Fedotova, Inga
    Feklina, Irina
    [J]. JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 519 - 519
  • [3] SOD1 TARGETED AS TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS
    Nelson, Roxanne
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2020, 182 (11) : 2475 - 2476
  • [4] SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
    Banci, Lucia
    Bertini, Ivano
    Boca, Mirela
    Girotto, Stefania
    Martinelli, Manuele
    Valentine, Joan Selverstone
    Vieru, Miguela
    [J]. PLOS ONE, 2008, 3 (02):
  • [5] An Investigation of SOD1 Behaviour in Amyotrophic Lateral Sclerosis
    Stevens, James C.
    Bros-Facer, Virginie
    Hendriks, William
    van Minnen, Jan
    Greensmith, Linda
    Martin, Joanne E.
    Schiavo, Giampietro
    Fisher, Elizabeth M. C.
    [J]. NEUROLOGY, 2009, 72 (11) : A368 - A368
  • [6] Neurochemistry of SOD1 and familial amyotrophic lateral sclerosis
    Carrì, MT
    Ceroni, M
    Ferri, A
    Gabbianelli, R
    Casciati, A
    Costa, A
    [J]. FUNCTIONAL NEUROLOGY, 2001, 16 (01) : 73 - 82
  • [7] Amyotrophic lateral sclerosis and SOD1 gene: An overview
    Ceroni, M
    Curti, D
    Alimonti, D
    [J]. FUNCTIONAL NEUROLOGY, 2001, 16 (04) : 171 - 180
  • [8] SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis
    P. Wicks
    S. Abrahams
    B. Papps
    A. Al-Chalabi
    C. E. Shaw
    P. N. Leigh
    L. H. Goldstein
    [J]. Journal of Neurology, 2009, 256 : 234 - 241
  • [9] Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
    Kaur, Simran J.
    McKeown, Stephanie R.
    Rashid, Shazia
    [J]. GENE, 2016, 577 (02) : 109 - 118
  • [10] Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
    Bastien Paré
    Manuela Lehmann
    Marie Beaudin
    Ulrika Nordström
    Stephan Saikali
    Jean-Pierre Julien
    Jonathan D. Gilthorpe
    Stefan L. Marklund
    Neil R. Cashman
    Peter M. Andersen
    Karin Forsberg
    Nicolas Dupré
    Peter Gould
    Thomas Brännström
    François Gros-Louis
    [J]. Scientific Reports, 8